| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $82.1M | +77.4% |
| SG&A Expense | $70.9M | +701.1% |
| Operating Income | -$153.0M | -177.6% |
| Interest Expense | $215K | — |
| Pre-tax Income | -$147.2M | -167.2% |
| Income Tax | $896K | +2257.9% |
| Net Income | -$54.5M | +1.2% |
| EPS (Basic) | -$0.23 | — |
| EPS (Diluted) | -$0.23 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $490.3M | — |
| Current Assets | $504.7M | — |
| Total Assets | $518.0M | +106.2% |
| Current Liabilities | $10.9M | +478.4% |
| Total Liabilities | $13.1M | +36.3% |
| Stockholders' Equity | -$1.10B | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.1M | -53.3% |
| Capital Expenditures | $1.8M | -64.4% |
| Investing Cash Flow | -$1.7M | +66.5% |
| Financing Cash Flow | $548.5M | +667.5% |
| Free Cash Flow | -$78.9M | -42.2% |
| — |